To Top

Community

Emilie Branch

Emilie is responsible for strategic content development based on scientific areas of specialty for Nice Insight research articles and for assisting client content development across a range of industry channels. Prior to joining Nice Insight, Emilie worked at a strategy-based consulting firm focused on consumer ethnographic research. She also has experience as a contributing editor, and has worked as a freelance writer for a host of news and trends-related publications

Contribution
Drug Development

Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties

PAO-M12-17-NI-025
Abuse Deterrence

Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow

PAO-M12-17-NI-012
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

PAO-M12-17-NI-004
Non-Opioid

SiteOne Therapeutics Garners US Department of Defense Award

PAO-M11-17-NI-036
CRISPR

CRISPR Technology Could Enable New Treatments for Resistant Fungal Infections

PAO-M11-17-NI-006
Research

Don’t Be Scared: New Insight into How the Brain Learns Fear

PAO-M10-17-NI-040
Stem Cell Therapy

Aging Frailty Stem Cell Therapy Advances

PAO-M10-17-NI-025
Vaccine

Leprosy Vaccine in Human Trials

PAO-M10-17-NI-021
Vaccine

Merck, J&J Receive BARDA Funding for Ebola Vaccine Development

PAO-M10-17-NI-019
FDA Approval

FDA Approves New, Implantable Sleep Apnea Treatment

PAO-M10-17-NI-016
Drug Development

New Insulin Formulation Improves Mealtime Glycemic Control

PAO-M10-17-NI-011
Innovation

New Plant Will Supply Large Numbers of Genetically Modified Mosquitos

PAO-M10-17-NI-008
3D Bioprinting

Printing Human Organs — One Step Closer to Reality

PAO-M10-17-NI-004
Formulation

DNA Binding Protein May Increase Ovarian Cancer Survival

PAO-M09-17-NI-034
Biosimilar

FDA Approves First Biosimilar Treatment for Multiple Cancers

PAO-M09-17-NI-030
Innovation

FDA Green Lights Mobile App to Help Treat Drug Abuse

PAO-M09-17-NI-022
API

Becoming Bioavailable

MCO-M07-17-NI-021
Innovation

Women Gain New Control Over Mammogram Discomfort

PAO-M09-17-NI-016
FDA Approval

US Now Has an Approved Treatment for Chagas Disease

PAO-M09-17-NI-012
Drug Development

Novel Genetic Test Helps Confirm Opioid Addiction Risk

PAO-M09-17-NI-006
Oncology

Vitamin C: Prostate Cancer’s New Foe

PAO-M08-17-NI-039
Combination Therapy

Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment

PAO-M08-17-NI-035
Research

Walgreens Introduces Center for Health & Wellbeing Research Website

PAO-M08-17-NI-031
FDA

FDA Makes Waves with Generic Approvals

PAO-M08-17-NI-024
Partnership

Academic-Industry Partnership Receives Funds to Develop Ebola Vaccine

PAO-M08-17-NI-021
NDA

Kite Submits Investigational New Drug Application for KITE-585

PAO-M08-17-NI-018
Microbiome

Personalized Genetic Screening Launches in the UK

PAO-M08-17-NI-014
//Fix for text overflow in cards